DK1652526T3 - Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse - Google Patents

Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse

Info

Publication number
DK1652526T3
DK1652526T3 DK06101005T DK06101005T DK1652526T3 DK 1652526 T3 DK1652526 T3 DK 1652526T3 DK 06101005 T DK06101005 T DK 06101005T DK 06101005 T DK06101005 T DK 06101005T DK 1652526 T3 DK1652526 T3 DK 1652526T3
Authority
DK
Denmark
Prior art keywords
estra
benzodioxol
dien
propynyl
hydroxy
Prior art date
Application number
DK06101005T
Other languages
Danish (da)
English (en)
Inventor
Cornelis Sennef
B W M M Bernardus Peeters
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1652526T3 publication Critical patent/DK1652526T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06101005T 2001-10-26 2002-10-21 Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse DK1652526T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26
PCT/EP2002/011732 WO2003037354A1 (en) 2001-10-26 2002-10-21 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Publications (1)

Publication Number Publication Date
DK1652526T3 true DK1652526T3 (da) 2009-05-18

Family

ID=8181136

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06101005T DK1652526T3 (da) 2001-10-26 2002-10-21 Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse

Country Status (27)

Country Link
US (1) US20040266863A1 (no)
EP (2) EP1652526B1 (no)
JP (1) JP4647909B2 (no)
KR (1) KR20050038580A (no)
CN (1) CN100531738C (no)
AT (2) ATE420649T1 (no)
AU (1) AU2002348996B2 (no)
BR (1) BR0213466A (no)
CA (1) CA2463446C (no)
CY (1) CY1110173T1 (no)
DE (2) DE60209248D1 (no)
DK (1) DK1652526T3 (no)
EC (1) ECSP045080A (no)
ES (1) ES2319563T3 (no)
HK (1) HK1087357A1 (no)
HR (1) HRP20040370B1 (no)
HU (1) HUP0500070A3 (no)
IL (2) IL161248A0 (no)
IS (1) IS2702B (no)
MX (1) MXPA04003781A (no)
NO (1) NO332978B1 (no)
NZ (1) NZ532429A (no)
PL (1) PL206687B1 (no)
PT (1) PT1652526E (no)
RU (1) RU2302245C2 (no)
WO (1) WO2003037354A1 (no)
ZA (1) ZA200403088B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
MX2007006045A (es) * 2004-11-19 2007-06-13 Organon Nv Combinacion farmaceutica que comprende inhibidor selectivo de reabsorcion de serotonina y antagonista del receptor de glucocorticoide para tratamiento de depresion.
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
JP2009535430A (ja) * 2006-05-02 2009-10-01 コーセプト セラピューティクス， インコーポレイテッド Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
US8658128B2 (en) 2011-02-03 2014-02-25 Pop Test Cortisol Llc System and method for diagnosis and treatment
EP2699245A4 (en) * 2011-04-18 2014-12-10 Pop Test Cortisol Llc TREATMENT AGAINST HAIR LOSS
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
DE69835225T2 (de) * 1997-10-06 2007-07-05 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
DK1370268T3 (da) * 2001-03-23 2009-09-14 Corcept Therapeutics Inc Fremgangsmåde til behandling af stresssygdomme under anvendelse af glucocorticoid-receptor-specifikke antagonister
JP2005512949A (ja) * 2001-05-04 2005-05-12 コーセプト セラピューティクス， インコーポレイテッド グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法
IL160649A0 (en) * 2001-08-31 2004-07-25 Corcept Therapeutics Inc Methods for inhibiting cognitive deterioration in adults with down syndrome

Also Published As

Publication number Publication date
HUP0500070A2 (hu) 2005-04-28
ES2319563T3 (es) 2009-05-08
CA2463446A1 (en) 2003-05-08
CA2463446C (en) 2010-02-23
ATE420649T1 (de) 2009-01-15
IL161248A0 (en) 2004-09-27
BR0213466A (pt) 2004-11-09
CN100531738C (zh) 2009-08-26
NZ532429A (en) 2004-10-29
US20040266863A1 (en) 2004-12-30
RU2004116082A (ru) 2005-05-10
NO20041651L (no) 2004-04-23
RU2302245C2 (ru) 2007-07-10
KR20050038580A (ko) 2005-04-27
CY1110173T1 (el) 2015-01-14
EP1441739B1 (en) 2006-02-15
HRP20040370B1 (en) 2012-09-30
AU2002348996B2 (en) 2008-06-05
EP1652526B1 (en) 2009-01-14
DE60230936D1 (de) 2009-03-05
IS7204A (is) 2004-03-31
PL206687B1 (pl) 2010-09-30
MXPA04003781A (es) 2004-07-30
JP2005521637A (ja) 2005-07-21
EP1441739A1 (en) 2004-08-04
NO332978B1 (no) 2013-02-11
DE60209248D1 (de) 2006-04-20
JP4647909B2 (ja) 2011-03-09
ECSP045080A (es) 2004-06-28
PT1652526E (pt) 2009-02-06
IL161248A (en) 2010-12-30
HK1087357A1 (en) 2006-10-13
WO2003037354A1 (en) 2003-05-08
CN1582153A (zh) 2005-02-16
PL369261A1 (en) 2005-04-18
HUP0500070A3 (en) 2012-09-28
ATE317700T1 (de) 2006-03-15
HRP20040370A2 (en) 2004-08-31
ZA200403088B (en) 2005-01-24
IS2702B (is) 2010-11-15
EP1652526A3 (en) 2006-08-02
EP1652526A2 (en) 2006-05-03

Similar Documents

Publication Publication Date Title
UA83620C2 (ru) Замещенные бензоксазолы и их аналоги как эстрогенные агенты
PT102548A (pt) Formulacao farmaceutica para administracao por injeccao do composto 7alfa-¬9-(4,4,5,5,5-pentafluoropentilsulfinil)-nonil| estra-1,3,5(10)-trieno-3,17beta-diol (fulvestrant)
BR0215042A (pt) fenil-naftalenos substituìdos como agentes estrogênicos
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
HK1087357A1 (en) Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.
CY1104981T1 (el) Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
MXPA04005784A (es) 2-fenilbenzofuranos sustituidos como agentes estrogenitos.
DK0712311T3 (da) Antiglucocorticoidsteroider til behandling af angstlidelser
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
HUP0500346A2 (hu) Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására
NO996442L (no) Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
HRP20090225T1 (en) Pharmaceutical compositions based on nk2 antagonists for pediatric use
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
EA200701091A1 (ru) Противозачаточный фармацевтический препарат
AR018313A1 (es) Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo
RS50350B (sr) Upotreba 11beta-(4-acetilfenil)-17beta-hidroksi-17alfa-(1,1,2,2,2-pentafluoretil)estra-4,9-dien-3-ona za pripremanje medikamenta za lečenje kancera dojke, jajnika, endometrijuma, mijeloma i meningioma
BR0107179A (pt) Amidinas cìclicas e acìclicas e composições farmacêuticas contendo as mesmas para uso como agentes de ligação de receptor de progesterona
DK1937274T3 (da) Anvendelse af estradiolvalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blødning i enhed med en oral kontraception
RS50389B (sr) Upotreba antiprogestina za profilaksu i lečenje hormonskih zavisnih bolesti
NO20022712L (no) Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene
BR0015112A (pt) Composto, método para uso do mesmo, e, produto farmacêutico